Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacinta Holmes

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancers|June 19, 2024
Different Patterns of Care and Survival Outcomes in Transplant-Centre Managed Patients with Early-Stage HCC: Real-World Data from an Australian Multi-Centre Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie L Ngu, et al.
Cancers|September 14, 2024
Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie L Ngu, et al.
Nature Communications|August 29, 2024
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infectionAtish Mukherji, Frank Jühling, Yogy Simanjuntak, et al.
Hepatology Communications|April 1, 2026
The diagnosis and management of portal hypertension in cirrhosis: The Gastroenterological Society of Australia consensusAvik Majumdar, Jacinta Holmes, Stuart K Roberts, et al.
Hepatology International|March 3, 2026
Australian best practice recommendations for transjugular intrahepatic portosystemic shunt (TIPS) in portal hypertension: a consensus statementEric Kalo, Jacinta Holmes, Purnima Bhat, et al.
The New England Journal of Medicine|May 28, 2026
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus InfectionJinlin Hou, Seng-Gee Lim, Maria Buti, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancers|June 19, 2024
Different Patterns of Care and Survival Outcomes in Transplant-Centre Managed Patients with Early-Stage HCC: Real-World Data from an Australian Multi-Centre Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie L Ngu, et al.
Cancers|September 14, 2024
Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie L Ngu, et al.
Nature Communications|August 29, 2024
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infectionAtish Mukherji, Frank Jühling, Yogy Simanjuntak, et al.
Hepatology Communications|April 1, 2026
The diagnosis and management of portal hypertension in cirrhosis: The Gastroenterological Society of Australia consensusAvik Majumdar, Jacinta Holmes, Stuart K Roberts, et al.
Hepatology International|March 3, 2026
Australian best practice recommendations for transjugular intrahepatic portosystemic shunt (TIPS) in portal hypertension: a consensus statementEric Kalo, Jacinta Holmes, Purnima Bhat, et al.
The New England Journal of Medicine|May 28, 2026
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus InfectionJinlin Hou, Seng-Gee Lim, Maria Buti, et al.
Pageof 2